Skip to main content

Clinical Workflow

AMP, Fuse Oncology Launch FuseRx Radiation Workflow Pilot in Syracuse

Image
AMP, Fuse Oncology Launch FuseRx Radiation Workflow Pilot in Syracuse

Syracuse – – September 28, 2026 -- Fuse Oncology and Associated Medical Professionals of NY (AMP), an affiliate of U.S. Urology Partners, a General Atlantic company, have launched a proof of concept for FuseRx, a clinical workflow platform for radiation oncology, at AMP's Center of Advanced Radiation Excellence in Syracuse.

Prostate cancer volume drives the test case

The American Cancer Society projects about 333,800 new U.S. prostate cancer cases in 2026, making it the most common cancer in American men after skin cancer. Roughly a third of men with localized disease receive radiation as primary treatment, a pathway that typically starts with a urologist diagnosis before crossing into separate oncology systems.

Mindray Launches SV70 Ventilator to Fill Philips V60 Gap

Image
Mindray Launches SV70 Ventilator to Fill Philips V60 Gap

United States – September 18, 2026 -- Mindray North America has launched the SV70 non-invasive ventilator in the United States, targeting respiratory departments left scrambling after Philips withdrew its V60 device, the previous clinical standard in non-invasive ventilation.

Philips V60 withdrawal forces hospitals into fleet-wide equipment replacements

The exit of the V60 from the market has created operational and financial strain on respiratory departments, pushing hospitals into large-scale replacement cycles while they try to preserve clinical familiarity, workflow continuity and patient safety. Mindray designed the SV70 specifically to absorb that transition without disrupting existing clinical routines.